Most AI advisory falls into one of two camps: all strategy, or all engineering. Depend.AI was built to do both.
I started Depend.AI after twenty years building AI systems in healthcare: at the research bench, in the engineering function, then at the executive table. What I see now in conversations with funds, and their portfolios: boards being handed AI quotes and roadmaps by agencies, and no one in the room they trust to tell good advice from bad.
Depend.AI is the firm I built for those rooms.
Two decades of building AI inside healthcare.
Most organisations in regulated markets hit a recurring problem when they look for AI advisory. They find strategy firms producing frameworks and governance decks without the engineering depth to know whether the advice can be built to the standard a regulator sets. The alternative is engineering shops moving fast on prototypes and integrations, without the accountability that a board or regulator demands when those systems are running in production.
Neither half is sufficient when the AI system has to withstand that kind of scrutiny.
That is the gap Depend.AI exists to close. The advisory carries weight because it draws on real production engineering. The engineering is accountable because it is shaped by the strategy that regulated markets require.
Depend.AI works with investors and operators where the quality of AI advice materially affects the outcome. If that's your situation, get in touch.
London, UK · Depend.AI